## CCL: Carnival Corporation - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 1.41 indicates fundamental undervaluation. Quality metrics strong (ROE 26%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($26.48)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Carnival Corporation & plc (CCL): Navigating Market Waves Ahead of Earnings Announcement**
- Source: Meyka | 20251216T060853 | Somewhat-Bullish | Relevance: 100%
- Carnival Corporation (CCL) is preparing for its earnings announcement on December 19, 2025, with its stock currently at $28.59, reflecting a 3.51% increase. Technical indicators suggest strong bullish momentum, and analysts anticipate an EPS of $0.24 on revenues of $6.21 billion. While there's a mixed analyst consensus, the company's strong technicals and a price target of $32.85 indicate cautious optimism for investors.

**2. Carnival Cruise Line to Launch New Ports in Australia and New Zealand, Opening More Opportunities for 2027 and Beyond**
- Source: Travel And Tour World | 20251218T030545 | Bullish | Relevance: 100%
- Carnival Cruise Line is expanding its operations in Australia and New Zealand by introducing Adelaide and Auckland as new homeports for 2027 and beyond. This expansion, featuring the Carnival Adventure, will offer new itineraries, including journeys to Norfolk Island, Fiji, Vanuatu, and New Caledonia, alongside continued year-round sailings from Sydney and Brisbane. The move aims to provide greater flexibility, value, and travel options for guests in the region, catering to diverse preferences with both short getaways and extended voyages.

**3. TD Cowen Adjusts Price Target on Carnival to $35 From $37, Maintains Buy Rating**
- Source: marketscreener.com | 20251217T120931 | Neutral | Relevance: 100%
- TD Cowen has adjusted its price target for Carnival Corporation (CCL) to $35, down from the previous $37, while reaffirming its Buy rating on the stock. This adjustment comes amidst other analyst revisions for Carnival, including Barclays trimming its target and Susquehanna increasing its target, reflecting varying outlooks on the cruise line industry. Despite the mixed adjustments, several firms like Jefferies, Citigroup, Wells Fargo, and Goldman Sachs maintain Buy or Overweight ratings on Carnival.

**4. SEABOURN ANNOUNCES 2028 'CAPE TO CAPE' 120-DAY WORLD CRUISE ON SEABOURN QUEST**
- Source: Finviz | 20251217T211045 | Bullish | Relevance: 98%
- Seabourn has announced its 2028 'Cape to Cape' 120-day World Cruise aboard the Seabourn Quest, celebrating 40 years of luxury cruising. This journey will offer the first complimentary expedition-style experiences on a Seabourn world cruise, exploring five continents and over 50 destinations, including Antarctica and several UNESCO World Heritage Sites. Guests can choose between a 120-day Miami to Dover voyage or a 112-day option to Lisbon, both featuring extensive amenities and an early booking advantage.

**5. Will Carnival Corp. Lead Cruise Line Stocks Higher in 2026?**
- Source: www.sharewise.com | 20251217T041045 | Somewhat-Bullish | Relevance: 98%
- Cruise line stocks, including Carnival Corp., Royal Caribbean, and Norwegian Cruise Line, have seen recent gains, but Carnival has lagged behind its rivals in stock performance this past month. Investors are now looking to Carnival's upcoming fiscal fourth-quarter results, due Friday morning, to see if it can turn the tide and lead the sector higher after a disappointing previous quarter. The article questions whether Carnival can outperform its competitors and lead the rally into the next year.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | UBS | $37 | $35 | +6% |
| 2025-12-17 | Barclays | $36 | $37 | -3% |
| 2025-12-16 | Susquehanna | $40 | $35 | +14% |
| 2025-12-15 | Jefferies | $37 | $34 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | UBS | main | Buy |
| 2025-12-17 | Barclays | main | Overweight |
| 2025-12-16 | Susquehanna | main | Positive |
| 2025-12-15 | Jefferies | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 9 / 1 |

**Top Holders:**
- Vanguard Group Inc: 10.9% (+0.9%)
- Blackrock Inc.: 6.8% (+4.6%)
- State Street Corpora: 4.1% (+4.0%)
- JPMORGAN CHASE & CO: 3.9% (+80.0%)
- Barrow, Hanley Mewhi: 3.1% (+0.8%)

### Key Risks

1. High beta (2.54) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 4 raises (avg +8%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +1.8% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.41 suggests fair value with growth premium. Forward P/E 11.7x attractive for 12% earnings growth. Quality metrics strong (ROE 26%). Analyst sentiment positive (4 raises, avg +8%). Institutional flow bullish (9 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.4B |
| Beta | 2.54 |
| 52W Range | $15.07 - $32.80 |
| Short Interest | 5.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.41 |
| Forward P/E | 11.7 |
| Current P/E | 13.1 |
| YoY Growth | 12.1% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 5.9% to 7.7% (+1.8% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 93rd percentile. MRS_5 at 0.6% confirms short-term momentum alignment. AM_20 at 7.0% shows strong absolute momentum above own 20MA. Outperforming sector by 3.6pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60. OFD pattern: -DLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.73% (CS: 93) | Strong |
| RSI_14 | 59.9 | Neutral |
| MACD Histogram | 0.36 | Bullish |
| vs SMA20 | 1.070x | Above |
| vs SMA50 | 1.039x | Above |
| vs SMA200 | 1.098x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $28.32
- **Stop Loss:** $26.48 (6.5% risk)
- **Target:** $32.00 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 619
- **Position Value:** $17,530.08
- **Portfolio %:** 17.53%
- **Risk Dollars:** $1,140.00
- **Risk Per Trade:** 1.14%
- **Modifiers:** L1 95% | L2 120% | Combined 1.14x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2025-12-18 (Est: $0.25)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.32 | $1.43 | +8.5% |
| 2025Q2 | $0.24 | $0.35 | +45.3% |
| 2025Q1 | $0.02 | $0.13 | +485.1% |
| 2024Q4 | $0.07 | $0.14 | +94.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*